Molecular genetic diagnosis of inherited metabolic disease;Molekylærbiologisk diagnostikk av arvelige stoffskiftesykdommer

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 11, 1998, Pages 1737-1742

  Christensen, Benedicte ^a   Berg, Kåre ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GENE THERAPY; GENETIC COUNSELING; GENETIC PROCEDURES; GENETICS; HUMAN; INBORN ERROR OF METABOLISM; MEDICAL GENETICS; METABOLIC DISORDER; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; REVIEW;

DNA MUTATIONAL ANALYSIS; GENE THERAPY; GENETIC COUNSELING; GENETIC TECHNIQUES; GENETICS, MEDICAL; HUMANS; METABOLIC DISEASES; METABOLISM, INBORN ERRORS; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS;

EID: 0032580105     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. McKusick VA, red. Mendelian inheritance in man. Catalogs of human genes and genetic disorders. 11. utg. Baltimore: Johns Hopkins University Press, 1994.
2. Scriver CR, Beaudet AL, Sly WS, Valle D, red. The metabolic and molecular bases of inherited disease. Baltimore: McGraw-Hill, 1995.
3. Foiling A. Ueber die Ausscheidung der Phenylbrenztraubensaeure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillitaet. Ztschr Physiol Chem 1934; 227: 169-76.
4. Refsum S. Heredopathia atactica polyneuritiformis. J Nerv Ment Dis 1952; 116: 1046-50.
5. Mierau GW, Weeks DA. Role of electron microscopy in the diagnosis of metabolic storage diseases affecting the nervous system of children. Ultrastruct Pathol 1997; 21: 345-54.
6. Pettersen RD, Saugstad OD, Heyerdahl S, Motzfeldt K, Lie SO. Screening av nyfødte i Norge for alvorlig metabolsk sykdom. Tidsskr Nor Lægeforen 1995; 115: 584-7.
7. Eiken HG, Knappskog PM, Motzfeldt K, Boman H, Apold J. Phenylketonuria genotypes correlated to metabolic phenotype groups in Norway. Eur J Pediatr 1996; 155: 554-60.
8. Saugstad LF. Genetic, epidemiological and clinical studies of phenylketonuria (oligophrenia phenylpyrouvica Følling) in Norway. Doktorgrad. Oslo: Universitetet i Oslo, 1975.
9. Beutler E, McKusick VA, Motulsky AG, Scriver CR, Hutchinson F. Mutation nomenclature: nicknames, systematic names, and unique identifiers. Hum Mutat 1996; 8: 203-6.
10. Goyette P, Christensen B, Rosenblatt DS, Rozen R. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. Am J Hum Genet 1996; 59: 1268-75.
11. Raben N, Sherman JB. Mutations in muscle phosphofructokinase gene. Hum Mutat 1995; 6: 1-6.
12. Douar AM, Mosser J, Sarde CO, Lopez J, Mandel JL, Aubourg P. X-linked adrenoleukodystrophy gene: identification of a candidate gene by positional cloning. Biomed Pharmacother 1994; 48: 215-8.
13. Worman HJ. Molecular biological methods in diagnosis and treatment of liver diseases. Clin Chem 1997; 43: 1476-86.
14. Hale DE, Cornell JE, Bennett MJ. Stability of long-chain and short-chain 3-hydroxyacyl-CoA dehydrogenase activity in postmortem liver. Clin Chem 1997; 43: 273-8.
15. Leren TP, Bakken KS, Rodningen OK, Gundersen KE, Sundvold H, Berg K et al. Genteknologisk diagnostikk av familiær hyperkolesterolemi. Tidsskr Nor Lægeforen 1997; 117: 678-81.
16. Scriver CR, Byck S, Prevost L, Hoang L. The phenylalanine hydroxylase locus: a marker for the history of phenylketonuria and human genetic diversity. PAH Mutation Analysis Consortium. Ciba Found Symp 1996; 197: 73-90.
17. Zschocke J, Mallory JP, Eiken HG, Nevin NC. Phenylketonuria and the peoples of Northern Ireland. Hum Genet 1997; 100: 189-94.
18. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994; 7: 195-200.
19. Goyette P, Frosst P, Rosenblatt DS, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 1995; 56: 1052-9.
20. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
21. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ et al. 5,10 methylene-tetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996; 63: 610-4.
22. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1.
23. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098-102.
24. Christensen B, Rosenblatt DS, Chu RC, Ueland PM. Effect of methionine and nitrous oxide on homocysteine export and remethylation in fibroblasts from cystathionine synthase-deficient, cb1G, and cb1E patients. Pediatr Res 1994; 35: 3-9.
25. Christensen B. Folatmangel, kreft og medfødte misdannelser. Er del en sammenheng? Tidsskr Nor Lægeforen 1996; 116: 250-4.
26. Flotte TR, Carter BJ. In vivo gene therapy with adeno-associated virus vectors for cystic fibrosis. Adv Pharmacol 1997; 40: 85-101.
27. Friderici KH. Molecular diagnostics for cystic fibrosis. Clin Lab Med 1997; 17: 59-72.
28. Wagner JA, Gardner P. Toward cystic fibrosis gene therapy. Annu Rev Med 1997; 48: 203-16.
29. Braun SE, Pan D, Aronovich EL, Jonsson JJ, McIvor RS, Whitley CB. Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II). Hum Gene Ther 1996; 7: 283-90.
30. Cartier N, Lopez J, Moullier P, Rocchiccioli F, Rolland MO, Jorge P et al. Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc Natl Acad Sci U S A 1995; 92: 1674-8.
31. Mazurier F, Moreau-Gaudry F, Salesse S, Barbot C, Ged C, Reiffers J et al. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria. J Inherit Metab Dis 1997; 20: 247-57.
32. Harding AE. Molecular genetics of peripheral neuropathies. Baillieres Clin Neurol 1995; 4: 383-400.
33. Romeo G, McKusick VA. Phenotypic diversity, allelic series and modifier genes. Nat Genet 1994; 7: 451-3.